Skip to content

Effects of a Short-term Aerobic Interval Exercise Program on Cardiac Fat and Function in Women With Obesity: A Pilot Study

Effects of a Short-term Aerobic Interval Exercise Program on Cardiac Fat and Function in Women With Obesity: A Pilot Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04802005
Enrollment
0
Registered
2021-03-17
Start date
2021-03-16
Completion date
2021-04-16
Last updated
2021-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Cardiac fat, Cardiac function, Aerobic interval training, Cardiac Magnetic Resonance, Vascular health

Brief summary

The overall goal of this project is to the study the effects of an aerobic interval training program on cardiac fat, and its relationship to cardiac function using cardiac Magnetic Resonance Imaging.

Interventions

The aerobic interval training group

Sponsors

Southern Illinois University Edwardsville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* females, age 18-40 years old, body mass index (BMI) ≥ 30 kg/m2 and \< 39.9 kg/m2, without known metabolic and/or cardiovascular disease

Exclusion criteria

* known CV, metabolic or pulmonary diseases or conditions, muscular-skeletal injuries (i.e. spine, knees, hips or shoulders, taking medications that affect endocrine or cardiovascular function, hypertension, being engaged in moderate intensity exercise more than two times per week or moderate-high intensity training of any type and frequency, being pregnant, cigarette smoking, having non-removable pieces or devices incompatible with DXA and CMR assessment

Design outcomes

Primary

MeasureTime frameDescription
Changes in Cardiac Adipose Tissue (CAT)2 assessment points: at baseline and week 5CAT will be measured using cardiac Magnetic Resonance
Changes in Cardiac Function2 assessment points: at baseline and week 5Cardiac Function will be measured using cardiac Magnetic Resonance

Secondary

MeasureTime frameDescription
Changes in Body Composition2 assessment points: at baseline and week 5Body composition will be measured using dual-energy x-ray absorptiometry
Changes in Cardiorespiratory Function2 assessment points: at baseline and week 5Cardiorespiratory Function will be measured on a treadmill with a metabolic cart
Changes in Muscular Strength2 assessment points: at baseline and week 5Muscular Strength will be assessed through 1 repetition maximum (1RM).
Changes in Blood Pressure2 assessment points: at baseline and week 5Blood pressure will be measured using pulse wave analysis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026